Ergoteles LLC Kala Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.3 - $1.31 $65,838 - $287,493
219,461 New
219,461 $66,000
Q4 2020

Feb 11, 2021
SELL
$6.28 - $8.79 $91,254 - $127,727
-14,531 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$7.5 - $11.11 $108,982 - $161,439
14,531 New
14,531 $109,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $10.4M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email